Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer

J Clin Oncol. 2024 Aug 1;42(22):2632-2636. doi: 10.1200/JCO.23.02614. Epub 2024 Apr 9.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / immunology
  • Breast Neoplasms* / therapy
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Immunotherapy / methods
  • Neoadjuvant Therapy*
  • Receptor, ErbB-2* / metabolism
  • Receptors, Estrogen* / metabolism

Substances

  • Receptor, ErbB-2
  • Receptors, Estrogen
  • ERBB2 protein, human